🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our CSO, John Maher, shared his insights on #cancer therapeutics in 2025 with Labiotech.eu .eu Read the full article here👉 labiotech.eu/in-depth/oncol… #CellandGeneTherapy #CGT #CarTcellTherapy

Catch @LeucidBio’s VP of R&D Marc Davies at Hanson Wade’s CAR-TCR Summit from 25-27 Feb in London. Connect with Marc to learn more about how we are developing innovative therapies for refractory cancers utilising our proprietary Lateral CAR platform.

This International Women's Day (#IWD) Leucid_Bio is celebrating🎉the achievements of all women around the world🌎. At #Leucid we recognize our own incredible women who are propelling us forward in #CGT

In honour of🔬British Science Week🧪our CSO John Maher discusses the future outlook of UK life sciences with Jo Shorthouse from In Vivo Citeline. 🔭#BritishScienceWeek🧫is annual celebration organized by the British Science Association and UK Research and Innovation Read more here👉 bit.ly/3Fmtl52

🚨NEWS ALERT➡️The 2025 The Medicine Maker Power List is now live!🚨 🎉Congratulation to our Founder and CSO, John Maher, who has been selected as an honoree in this year’s Power List. 👀Check out the 2025 Power List below👇 #CARTcellTherapy #Oncology

Connect with our CEO Filippo Liverani Petti at #BioEquity, 12-14 May in Bruges. Hear the latest developments on Leucid_Bio’s pipeline of innovative cell therapies, where Filippo will present an update on the Company and its latest advancements. #BioEquityEurope2025 #CARTcellTherapy

.Leucid_Bio has dosed the first patient in the Phase 1 AERIAL trial of #LEU011 for solid tumours, following a successful first close of Series A1 financing. To learn more about AERIAL and our manufacturing collaboration with GOSH International, read the PR here👉 bit.ly/4j0nTTM

📢 Connect with @Leucid_Bio CEO Filippo Petti at #BIO2025 to learn more about our #AERIAL trial for NKG2DL-targeting CAR-T therapy #LEU011 for the treatment of solid tumours. Learn more here👉leucid.com Biotechnology Innovation Organization #CARTcellTherapy #CellTherapy